Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 4—April 2023

Yezo Virus Infection in Tick-Bitten Patient and Ticks, Northeastern China

Xiaolong Lv1, Ziyan Liu1, Liang Li1, Wenbo Xu, Yongxu Yuan, Xiaojie Liang, Li Zhang, Zhengkai Wei, Liyan Sui, Yinghua Zhao, Zhijun Hou, Feng Wei, Shuzhen Han, Quan Liu, and Zedong WangComments to Author 
Author affiliations: First Hospital of Jilin University, Changchun, China (Z. Liu, W. Xu, L. Sui, Y. Zhao, Q. Liu, Z. Wang); Inner Mongolia General Forestry Hospital, Yakeshi, China (X. Lv, S. Han); Jilin Agricultural University, Changchun (Z. Liu, Y. Yuan, X. Liang, F. Wei); Chinese Academy of Agricultural Sciences, Changchun (L. Li, L. Zhang, Q. Liu, Z. Wang); Foshan University, Foshan, China (Z. Wei, Q. Liu); Northeast Forestry University, Harbin, China (Z. Hou)

Cite This Article


We identified Yezo virus infection in a febrile patient who had a tick bite in northeastern China, where 0.5% of Ixodes persulcatus ticks were positive for viral RNA. Clinicians should be aware of this potential health threat and include this emerging virus in the differential diagnosis for tick-bitten patients in this region.

Tickborne orthonairoviruses have been considered a major public health threat worldwide (1). In China, other than Crimean-Congo hemorrhagic fever virus, there are 3 emerging orthonairoviruses: Tacheng tick virus 1 (2), Songling virus (3), and Beiji nairovirus (4). Those viruses have been associated with human febrile illness in northeastern and northwestern China.

Yezo virus (YEZV), a new tickborne orthonairovirus discovered in Japan in 2021, can cause acute febrile illness in humans, whose clinical symptoms include thrombocytopenia and leukopenia (5). We report a case of YEZV infection in a tick-bitten patient and provide molecular evidence of YEZV infection in ticks in northeastern China.

The Study

The research protocol was approved by the human bioethics committee of Inner Mongolia General Forestry Hospital and the First Hospital of Jilin University, China. During 2018–2020, a total of 402 blood samples from tick-bitten patients were collected at the Inner Mongolia General Forestry Hospital (164 in 2018, 97 in 2019, and 141 in 2020) for viral detection by using reverse transcription PCR (Appendix Table 1). Results showed that 1 sample collected in 2018 was YEZV positive.

Figure 1

Timeline of the clinical course for a tick-bitten person infected with Yezo virus, northeastern China.

Figure 1. Timeline of the clinical course for a tick-bitten person infected with Yezo virus, northeastern China.

The patient was a 33-year-old man who lived on a farm in the Oroqen Autonomous Banner of Hulunbuir, Inner Mongolia, northeastern China, who had no history of underlying diseases. On June 18, 2018, he noticed a tick embedded on his back after he grazed horses on a mountain. The tick was removed intact by using tweezers in a local clinic and identified as Ixodes persulcatus. At that time, no obvious clinical symptoms, such as rash, itching, and discomfort, occurred. However, fever developed, followed by light headache, dizziness, blurred vision, chest distress, shortness of breath, fatigue, and arthralgia in 1 week (Table 1; Figure 1). No gastrointestinal (e.g., nausea, vomit, diarrhea) or hemorrhagic (e.g., melena, petechia, and ecchymosis) symptoms occurred.

Laboratory tests identified lymphocytopenia and neutrophilia, which accounted for 15.0% and 75.9% of the total leukocyte count, respectively. However, leukocyte counts (4,460 cells/mL) and platelet counts (199,000 cells/mL) were within reference ranges. Serum levels of liver aminotransferases were slightly increased (alanine aminotransferase 40 U/L, aspartate aminotransferase 44 U/L, and γ-glutamyltransferase 124 U/L) (Appendix Table 2). The serum level of C-reactive protein increased to 11.1 mg/L.

The patient was hospitalized for 8 days. Headache, dizziness, and arthralgia continued throughout the hospitalization, whereas the clinical signs of fever, blurred vision, chest distress, shortness of breath, and fatigue were relieved or disappeared (Figure 1). Lymphopenia continued until day 5, but counts of leukocytes, platelets, and erythrocytes and the hemoglobin level were all within reference ranges. Evidence of liver damage continued through the discharge date (alanine aminotransferase 56 U/L and γ -glutamyltransferase 181 U/L).

A blood sample was collected at admission and was negative for the tick-borne pathogens that have been identified in northeastern China (Table 1). The patient was empirically given ribavirin (1 g), azithromycin (0.5 g), and rocephin (3 g) intravenously each day during the first 4 days of hospitalization (Table 1). Glycyrrhizin was used to treat liver injury. The patient was discharged on the 8th day of hospitalization, although some clinical manifestations, such as headache, dizziness, and arthralgia, were still present. Two weeks later, the patient had recovered completely.

During April 2020‒July 2021, a total of 2,830 ticks were collected from Heilongjiang, Jilin, and Inner Mongolia in northeastern China (214 Haemaphysalis japonica, 431 H. concinna, 1,110 Dermacentor silvarum, and 1,075 I. persulcatus) (Table 2). YEZV RNA was detected in I. persulcatus ticks by using reverse transcription PCR; overall prevalence was 0.5% (95% CI 0.2%–1.0%) (Table 2). The prevalence of YZEV infection in I. persulcatus ticks in Inner Mongolia, Heilongjiang, and Jilin varied from 0.4% to 0.5%. No positive sample was detected in other tick species.

We obtained complete genomes of 6 YEZV strains (1 from the patient and 5 from I. persulcatus ticks) by using specific primers (Appendix Table 1). YEZV has a genomic structure of typical orthonairoviruses (5). The complete genome of YEZV identified in this study included large (12,122-nt), medium (4,256-nt) and small (1,697-nt) segments (Appendix Table 3), which encoded a 3,938-aa large protein, a 1,356-aa glycoprotein precursor, and a 502-aa nucleocapsid (Appendix Figure 1). YEZV strain H-IM01 from the patient showed high sequence identities with those detected in ticks (T-HLJ01–03, T-JL01, and T-IM01) and nucleotide identities of 99.6%–100% (Appendix Tables 4, 5). Strains isolated from northeastern China were clustered with strains detected in tick-bitten patients in Japan and showed high nucleotide identities of 97.2%–98.8% (Appendix Tables 4, 5).

Figure 2

Phylogenetic analyses of Yezo virus from a tick-bitten person and Ixodes persulcatus ticks, northeastern China (red text), and references viruses. Sequences of representative viral strains were downloaded from National Center for Biotechnology Information public databases ( and aligned together using MEGA version 7.0 ( A bootstrapping analysis of 1,000 replicates were conducted, and values >70 were considered significant and are shown. Shading indicates Sulin virus genogroup strains (green) and Tamdy virus strain (blue). Numbers along branches are bootstrap values. Scale bar indicates amino acid substitutions per site.

Figure 2. Phylogenetic analyses of Yezo virus from a tick-bitten person and Ixodes persulcatusticks, northeastern China (red text), and references viruses. Sequences of representative viral strains were downloaded from National...

The YEZV strains from China were genetically related to Sulina virus discovered in I. ricinus ticks in Romania (6), showing complete genome nucleotide identities of 59.7%–70.3% and large protein amino acid identities of 82.3%–82.5%; they were grouped into the genogroup Sulina (Figure 2; Appendix Tables 4, 5, Figure 2) (5). Phylogenetic analysis indicated that viruses in the genogroup Sulina had a close relationship with Tamdy virus; those viruses showed nucleotide identities of ≈50% and large protein amino acid identities of ≈45% with each other. All viral genome sequences have been submitted to GenBank (Appendix Table 3).


Clinical manifestations of the YEZV-infected patient in China were milder than those reported for patients in Japan, where leukopenia, lymphocytopenia, thrombocytopenia, coagulation disorder, and increased levels of liver and heart enzymes have been observed (5); only mild lymphocytopenia and mildly increased levels of liver enzymes were found in the patient in this study. The 2 patients in Japan were a 59-year-old man and a 41-year-old man who had medical histories of hyperuricemia and hyperlipidemia, and the patient from China was 33-year-old man who had no underlying disease. The YEZV-infected patient in this study was given ribavirin on days 1–4, but the patients in Japan were not given ribavirin. The clinical signs of YEZV infection might be related to age, medical history, and medication. No gastrointestinal symptoms, such as nausea, vomiting, and diarrhea, or hemorrhagic symptoms, such as melena, petechia, and ecchymosis, occurred in any of the YEZV-infected patients.

The infection rate of YEZV was low (1/402) in tick-bitten patients in northeastern China, compared with YEZV patients in Japan (5/248). To date, no severe YEZV-infected patient has been reported, and the patients in the 2 countries recovered completely. Thus, active surveillance should be performed on the tick-bitten populations to evaluate the prevalence and clinical characteristics of YEZV infection in the studied regions.

YEZV RNA has been detected in H. megaspinosa, I. ovatus, and I. persulcatus ticks in Hokkaido, Japan, showing a prevalence of 0.0%–5.7% (5). In this study, YEZV was detected only in I. persulcatus ticks, showing a prevalence of 0.5% (95% CI 0.2%–1.0%), and other tick species, such as H. japonica, H. concinna, and D. silvarum, were negative for YEZV RNA. Those results indicate that I. persulcatus ticks might serve as a potential vector for YEZV in northeastern China.

YZEV was identified in a tick-bitten patient who had febrile illness and I. persulcatus tick bites in northeastern China. Phylogenetic analysis confirmed the association between febrile illness and the virus. To date, there are >8 pathogenetic tickborne viruses in humans and animals found in northeastern China: tickborne encephalitis virus (7), severe fever with thrombocytopenia syndrome virus (8), Nairobi sheep disease virus (9), Alongshan virus (10), Jingmen tick virus (11), Songling virus (3), Beiji nairovirus (4), and YEZV. Differential diagnosis of these tickborne viruses should be conducted in for febrile patients who have a history of tick bites in northeastern China.

Mr. Lv is a scientist at the Second Affiliated Hospital of Inner Mongolia University for the Nationalities, Inner Mongolia General Forestry Hospital, Yakeshi, China. His primary research interest is emerging tickborne diseases.



This study was supported by the National Key Research and Development Program of China (2022YFC2601900), the National Natural Science Foundation of China (82002165 and 32072887), the Outstanding Young Scholars Cultivating Plan of the First Hospital of Jilin University (2021-YQ-01), the Medical and Health Talent Special Project in Jilin Province of China (JLSWSRCZX2021-002), the Pearl River Talent Plan in Guangdong Province of China (2019CX01N111), and the Medical Innovation Team Project of Jilin University (2022JBGS02).



  1. Walker  PJ, Widen  SG, Wood  TG, Guzman  H, Tesh  RB, Vasilakis  N. A global genomic characterization of nairoviruses identifies nine discrete genogroups with distinctive structural characteristics and host-vector associations. Am J Trop Med Hyg. 2016;94:110722. DOIPubMedGoogle Scholar
  2. Liu  X, Zhang  X, Wang  Z, Dong  Z, Xie  S, Jiang  M, et al. A tentative Tamdy orthonairovirus related to febrile illness in northwestern China. Clin Infect Dis. 2020;70:215560. DOIPubMedGoogle Scholar
  3. Ma  J, Lv  XL, Zhang  X, Han  SZ, Wang  ZD, Li  L, et al. Identification of a new orthonairovirus associated with human febrile illness in China. Nat Med. 2021;27:4349. DOIPubMedGoogle Scholar
  4. Wang  YC, Wei  Z, Lv  X, Han  S, Wang  Z, Fan  C, et al. A new nairo-like virus associated with human febrile illness in China. Emerg Microbes Infect. 2021;10:12008. DOIPubMedGoogle Scholar
  5. Kodama  F, Yamaguchi  H, Park  E, Tatemoto  K, Sashika  M, Nakao  R, et al. A novel nairovirus associated with acute febrile illness in Hokkaido, Japan. Nat Commun. 2021;12:5539. DOIPubMedGoogle Scholar
  6. Tomazatos  A, von Possel  R, Pekarek  N, Holm  T, Rieger  T, Baum  H, et al. Discovery and genetic characterization of a novel orthonairovirus in Ixodes ricinus ticks from Danube Delta. Infect Genet Evol. 2021;88:104704. DOIPubMedGoogle Scholar
  7. Sun  RX, Lai  SJ, Yang  Y, Li  XL, Liu  K, Yao  HW, et al. Mapping the distribution of tick-borne encephalitis in mainland China. Ticks Tick Borne Dis. 2017;8:6319. DOIPubMedGoogle Scholar
  8. Zhang  X, Wang  N, Wang  Z, Che  L, Chen  C, Zhao  WZ, et al. First fatal infection and phylodynamic analysis of severe fever with thrombocytopenia syndrome virus in Jilin Province, northeastern China. Virol Sin. 2021;36:32932. DOIPubMedGoogle Scholar
  9. Gong  S, He  B, Wang  Z, Shang  L, Wei  F, Liu  Q, et al. Nairobi sheep disease virus RNA in ixodid ticks, China, 2013. Emerg Infect Dis. 2015;21:71820. DOIPubMedGoogle Scholar
  10. Wang  ZD, Wang  B, Wei  F, Han  SZ, Zhang  L, Yang  ZT, et al. A new segmented virus associated with human febrile illness in China. N Engl J Med. 2019;380:211625. DOIPubMedGoogle Scholar
  11. Jia  N, Liu  HB, Ni  XB, Bell-Sakyi  L, Zheng  YC, Song  JL, et al. Emergence of human infection with Jingmen tick virus in China: A retrospective study. EBioMedicine. 2019;43:31724. DOIPubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid2904.220885

Original Publication Date: March 16, 2023

1These authors contributed equally to this article.

Table of Contents – Volume 29, Number 4—April 2023

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Zedong Wang, Department of Infectious Diseases, Center of Infectious Diseases and Pathogen Biology, State Key Laboratory of Zoonotic Diseases, First Hospital of Jilin University, Changchun 130122, Jilin, China

Send To

10000 character(s) remaining.


Page created: January 28, 2023
Page updated: March 21, 2023
Page reviewed: March 21, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.